Systematic review and statistical analysis of the integrity of 33 randomized controlled trials

Neurology

Volumn 87, Issue 23, 2016, Pages 2391-2402

  Bolland, Mark J ^a   Avenell, Alison ^a   Gamble, Greg D ^a   Grey, Andrew ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; EMBASE; HIP FRACTURE; HUMAN; INFORMATION RETRIEVAL; MEDLINE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAMPLE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; MEASUREMENT ACCURACY; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; STATISTICS AND NUMERICAL DATA;

DATA ACCURACY; DATA INTERPRETATION, STATISTICAL; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85002610777     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003387     Document Type: Article

References (30)

1. Yentis SM. Lies, damn lies, and statistics. Anaesthesia 2012;67:455-456.
2. Carlisle JB. The analysis of 168 randomised controlled trials to test data integrity. Anaesthesia 2012;67:521-537.
3. Clarke CE. Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:510-511; author reply 511.
4. Poole KE, Warburton EA, Reeve J. Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 2005;65:1513-1514; author reply 1513-1514.
5. Caffrey N, Casey M, Walsh B. Substandard studies or substandard standard-of-care. J Bone Miner Res 2006; 21:491; author reply 492.
6. Halbekath JM, Schenk S, von Maxen A, Meyer G, Muhlhauser I. Risedronate for the prevention of hip fractures: concern about validity of trials. Arch Intern Med 2007;167:513-514; author reply 514-515.
7. Gotzsche PC, Hrobjartsson A, Maric K, Tendal B. Data extraction errors in meta-analyses that use standardized mean differences. JAMA 2007;298:430-437.
8. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993;328:460-464.
9. Reid IR, Ames RW, Orr-Walker BJ, et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000;109:362-370.
10. Reid IR, Lucas J, Wattie D, et al. Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab 2005;90:5212-5216.
11. Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med 2006; 119:777-785.
12. Bolland MJ, Grey AB, Horne AM, et al. Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. J Clin Endocrinol Metab 2007;92:1283-1288.
13. Grey A, Bolland M, Gamble G, et al. The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 2007;92: 1305-1310.
14. Reid IR, Cundy T, Grey AB, et al. Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 2007;92:2446-2452.
15. Reid IR, Ames R, Mason B, et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 2008;168:2276-2282.
16. Grey A, Bolland MJ, Wattie D, Horne A, Gamble G, Reid IR. The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebocontrolled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab 2009;94:538-544.
17. Grey A, Bolland M, Wong S, Horne A, Gamble G, Reid IR. Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab 2012;97:286-292.
18. Bolland MJ, Wilsher ML, Grey A, et al. Randomised controlled trial of vitamin D supplementation in sarcoidosis. BMJ Open 2013;3:e003562.
19. Grey A, Garg S, Dray M, et al. Low-dose fluoride in postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab 2013;98:2301-2307.
20. Grey A, Bolland M, Fenwick S, et al. The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial. Eur J Endocrinol 2014;170:257-264.
21. Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990;335:149-153.
22. Altman DG, Bland JM. How to randomise. BMJ 1999; 319:703-704.
23. Sato Y, Iwamoto J, Kanoko T, Satoh K. Retraction: amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res 2015;30:2328.
24. Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol Assess 2005;9:1-160.
25. Wells GA, Cranney A, Peterson J, et al. Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 2008:CD003376.
26. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009:CD000227.
27. Bauchner H, Fontanarosa PB. Expression of Concern: Sato et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-1088. JAMA 2015;313: 1914.
28. Sato Y, Iwamoto J, Kanoko T, Satoh K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res 2015; 30:1745.
29. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 2008;93:1217-1223.
30. Stevenson M, Lloyd-Jones M, Papaioannou D. Vitamin K to prevent fractures in older women: systematic review and economic evaluation. Health Technol Assess 2009;13:iii-xi, 1-134.